Biogen (BIIB) Morgan Stanley raised the target to $373 from $361
Analyst Ratings Coverage Morgan Stanley & Co. (Rank#1) has recently issued a research report, maintaining its “Overweight” rating on Biogen’s stock, signaling…
Browse research
Analyst Ratings Coverage Morgan Stanley & Co. (Rank#1) has recently issued a research report, maintaining its “Overweight” rating on Biogen’s stock, signaling…
US Stock Ratings AAL American Airlines Group AAL BNP Paribas Downgrade Outperform – Neutral 12 AMLX Amylyx Pharmaceuticals Inc AMLX H.C. Wainwright…
Analyst Ratings Coverage Stifel Nicolaus (Rank#24) on November 8th, issued a research report and lowered the 12 month target on Sandstorm Gold…
190 US Stock Ratings AdTheorent Holding Company Inc ADTH Needham & Company Maintains Buy 2 ADTRAN Inc ADTN Needham & Company Maintains…
Ratings for TSX/Venture ARR:CA Altius Renewable Royalties Corp ARR:CA PI Financial Target Down 13 AX-UN:CA Artis Real Estate Investment Trust AX-UN:CA Laurentian…